Advances in the treatment of macular corneal dystrophy
Macular corneal dystrophy(MCD)refers to corneal stromal dystrophy, which can cause progressive visual field defects. MCD belongs to autosomal recessive disease. Mutation of CHST 6 gene is considered to be a pathogenic factor. In general, full-thickness penetrating keratoplasty has become a standard...
Main Authors: | Wen-Qing Shi, Qi Lin, Yi Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2019-11-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2019/11/201911012.pdf |
Similar Items
-
Macular corneal dystrophy related to novel mutations of CHST6 in a Chinese family and clinical observation after penetrating keratoplasty
by: Dewei Li, et al.
Published: (2021-10-01) -
Corneal macular dystrophy. Case Presentation.
by: Leopoldo Garduño-Vieyra, et al.
Published: (2022-12-01) -
Medium-Term Clinical Outcomes of Deep Anterior Lamellar Keratoplasty versus Penetrating Keratoplasty for Macular Corneal Dystrophy
by: AlAraj A, et al.
Published: (2021-07-01) -
Detailed corneal and genetic characteristics of a pediatric patient with macular corneal dystrophy - case report
by: Anna Nowińska, et al.
Published: (2021-07-01) -
Histological findings of corneal tissue after failed phototherapeutic keratectomy in macular corneal dystrophy – a case report
by: Caroline Julia Gassel, et al.
Published: (2022-05-01)